Filter
170
Filtered Results: 170
Text search:
pharma
company
Featured
Recommendations
9
New Publications
46
Language
Document type
No document type
74
Studies & Reports
50
Guidelines
20
Manuals
11
Strategic & Response Plan
6
Fact sheets
4
Training Material
2
Situation Updates
2
Resource Platforms
1
Countries / Regions
Global
8
South Africa
8
India
8
Kenya
7
Ethiopia
6
Nigeria
5
Sierra Leone
4
Philippines
4
Western and Central Europe
4
Nepal
3
Uganda
3
Ukraine
2
Ghana
2
Senegal
2
Zimbabwe
2
Mongolia
2
Latin America and the Carribbean
2
Tanzania
2
Eastern Europe
2
China
1
Burkina Faso
1
Malaysia
1
Haiti
1
Germany
1
Argentina
1
Bangladesh
1
Papua New Guinea
1
Namibia
1
Sudan
1
Mali
1
Liberia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
33
Studies & Reports
10
Guidelines
9
Policies
8
Maternal Health
4
HIV & STI
4
Neonatal Care
4
Reproductive Health
4
Pharmacy & Technologies
4
Paediatrics
3
Pediatrics
3
Gynaecology & Obstetrics
3
Laboratory Quality Assurance
3
TB
3
Family Planning
2
Diabetes
2
COVID-19
2
Medical Devices & Equipment
2
Other
2
WASH
2
Surgery & Anaesthesia
2
Primary Health Care
2
Global Health
2
Hepatitis
1
Child Health
1
Community Health
1
Cancer Treatment & Resources
1
Infection Control & Prevention (IPC)
1
Public Health
1
Snakebites
1
Vaccine-preventable Diseases
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
Capacity Building
1
Statistics
1
Respiratory Infections
1
Health Systems
1
Women & Child Health
1
NTDs & Others
1
Parasitology
1
Water
1
Age & Elderly
1
Toolboxes
Country specific
8
Reports & Studies
6
Essential Medicines
5
Waste Managment
5
Clinical Aspects, Treatment & Prevention
4
Treatment & Prevention
4
Prices and Patents
4
Quality Assurance
4
Antiretroviral Treatment ART
4
Adults
3
International
3
Falsified & Substandard
3
Pharmacy Practice
3
Supply Chain & Store Management
3
Drug resistant TB
3
Assessment
3
Agriculture & Veterinary
2
Europe
2
Prevention & Control
2
Children & Adolescents
2
Opportunistic Infections
2
Studies
2
General
2
Country Specific
2
Communication Material
2
Fair Allocation & Ethical Aspects
2
Self-care
2
Pharmacy Management
2
Traditional & Herbal Medicines
2
Health Financing Toolbox
2
Human Rights & the Right to Health
2
Research & Access
2
Alcohol
1
ART Drug Resistance
1
Local Action
1
General Reports
1
Children with Disabilities
1
IPC
1
Background PTSD in children
1
Preparedness, Response & Risk Communication
1
Introduction to Global Health
1
Schizophrenia
1
Influenza
1
Stroke
1
Concepts of Global Health
1
Curricula & Core Competencies
1
General Studies & Reports
1
TB
1
Tools for Rational use
1
Advocacy
1
Training
1
Sustainable Development Goals
1
IEC Substance Use Disorders
1
Clinical Guidelines
1
Health Personnel
1
Public Health
1
Diagnostics & Laboratory Guidance
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
RCCE Guides & Manuals
1
Access & Strategy
1
Gambling
1
TB/HIV
1
Research & Pipeline
1
Hygiene
1
Primary Care
1
Triage
1
Climate Change General
1
Food environments
1
Model Formulary
1
Resuscitation
1
Epilepsy
1
Antimicrobial Resistance (AMR)
1
Studies & Reports
1
Overview, Studies & Reports
1
Yaws & other Endemic Treponematoses
1
Risk Factors
1
Women
1
Global Overview
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
General
1
Training
1
Tuberculosis
1
Prevention of mother-to-child transmission (PMTCT)
1
Self-harm & Suicide
1
Vision Loss & Blindness
1
General Public
1
TB/HIV Coinfection
1
Tobacco
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Overview & Statistics
1
Lobby and Advocacy
1
Eastern Europe & Central Asia
1
Recommended actions at international and national levels
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
Procedures Manual - Medicines registration in Madagascar - 2016 version
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
The procurement of essential medicines and other health products is a critical function in support of the effective discharge of WHO’s mandate, and WHO values the importance of the quality of essential medicines and health products that are supplied to countries. The first World Health Assembly in...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newborns from asphyxia at birth. For the efficient use of...
Lancet Glob Health 2021 Published Online December 13, 2021 https://doi.org/10.1016/S2214-109X(21)00463-
